The association between IgM and IgG antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis

被引:0
|
作者
Filippidou, N. [1 ]
Krashias, G. [2 ]
Pericleous, C. [3 ]
Rahman, A. [3 ]
Giles, I. [3 ]
Ioannou, Y. [3 ]
Anatolitou, A. [1 ]
Christodoulou, C. [2 ]
Pantzaris, M. [1 ]
Lambrianides, A. [1 ]
机构
[1] Cyprus Inst Neurol & Genet, Neurol Clin C, Nicosia, Cyprus
[2] Cyprus Inst Neurol & Genet, Dept Virol, Nicosia, Cyprus
[3] UCL, Ctr Rheumatol, London, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P883
引用
收藏
页码:444 / 445
页数:2
相关论文
共 50 条
  • [1] The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis
    Filippidou, Natalia
    Krashias, George
    Pericleous, Charis
    Rahman, Anisur
    Ioannou, Yiannis
    Giles, Ian
    Demetriou, Christiana
    Anatolitou, Afroditi
    Christodoulou, Christina
    Pantzaris, Marios
    Lambrianides, Anastasia
    MOLECULAR IMMUNOLOGY, 2016, 75 : 161 - 167
  • [2] Association of β2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia
    Voss, A
    Jacobsen, S
    Heegaard, NHH
    LUPUS, 2001, 10 (08) : 533 - 538
  • [3] Antibodies against domain I of β2-glycoprotein I: the one and only?
    Pelkmans, L.
    de laat, B.
    LUPUS, 2012, 21 (07) : 769 - 772
  • [4] β2-glycoprotein I-dependent anticardiolipin antibody is reactive to both β2-glycoprotein I oxidized as well as β2-glycoprotein I reduced cardiolipin
    Matsuda, J
    Gohchi, K
    Gotoh, M
    Kawasugi, K
    Katoh, M
    THROMBOSIS RESEARCH, 1999, 95 (01) : 63 - 67
  • [5] Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
    Raimondo, Maria Gabriella
    Pericleous, Charis
    Radziszewska, Anna
    Borghi, Maria Orietta
    Pierangeli, Silvia
    Meroni, Pier Luigi
    Giles, Ian
    Rahman, Anisur
    Ioannou, Yiannis
    PLOS ONE, 2017, 12 (10):
  • [6] β2-glycoprotein I-anti-β2-glycoprotein I interaction
    Koike, T
    Ichikawa, K
    Atsumi, T
    Kasahara, H
    Matsuura, E
    JOURNAL OF AUTOIMMUNITY, 2000, 15 (02) : 97 - 100
  • [7] β2-glycoprotein I and anti-β2-glycoprotein I antibodies:: Where are we now?
    Inanç, M
    Radway-Bright, EL
    Isenberg, DA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (12): : 1247 - 1257
  • [8] Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change
    de Laat, B
    Derksen, RHWM
    van Lummel, M
    Pennings, MTT
    de Groot, PG
    BLOOD, 2006, 107 (05) : 1916 - 1924
  • [9] β2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of β2-glycoprotein I
    McNeeley, PA
    Dlott, JS
    Furie, RA
    Jack, RM
    Ortel, TL
    Triplett, DA
    Victoria, EJ
    Linnik, MD
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (02) : 590 - 595
  • [10] Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope
    de Laat, Bas
    van Berkel, Miranda
    Urbanus, Rolf T.
    Siregar, Berdien
    de Groot, Philip G.
    Gebbink, Martijn F.
    Maas, Coen
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 3960 - 3968